Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

642 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
The use and performance of productivity scales to evaluate presenteeism in mood disorders.
Despiégel N, Danchenko N, François C, Lensberg B, Drummond MF. Despiégel N, et al. Value Health. 2012 Dec;15(8):1148-61. doi: 10.1016/j.jval.2012.08.2206. Value Health. 2012. PMID: 23244819 Review.
Challenges in measuring and valuing productivity costs, and their relevance in mood disorders.
Lensberg BR, Drummond MF, Danchenko N, Despiégel N, François C. Lensberg BR, et al. Clinicoecon Outcomes Res. 2013 Nov 18;5:565-73. doi: 10.2147/CEOR.S44866. eCollection 2013. Clinicoecon Outcomes Res. 2013. PMID: 24273412 Free PMC article. Review.
Escitalopram and duloxetine in major depressive disorder: a pharmacoeconomic comparison using UK cost data.
Wade AG, Fernández JL, François C, Hansen K, Danchenko N, Despiegel N. Wade AG, et al. Pharmacoeconomics. 2008;26(11):969-81. doi: 10.2165/00019053-200826110-00008. Pharmacoeconomics. 2008. PMID: 18850765 Clinical Trial.
Results and validation of an index to measure health state of patients with depression in automated healthcare databases.
Lamy FX, Falissard B, François C, Lançon C, Llorca PM, Tanasescu A, Touya M, Verpillat P, Wade AG, Saragoussi D. Lamy FX, et al. J Mark Access Health Policy. 2019 Jan 22;7(1):1562860. doi: 10.1080/20016689.2018.1562860. eCollection 2019. J Mark Access Health Policy. 2019. PMID: 30719242 Free PMC article.
Creating an index to measure health state of depressed patients in automated healthcare databases: the methodology.
François C, Tanasescu A, Lamy FX, Despiegel N, Falissard B, Chalem Y, Lançon C, Llorca PM, Saragoussi D, Verpillat P, Wade AG, Zighed DA. François C, et al. J Mark Access Health Policy. 2017 Sep 13;5(1):1372025. doi: 10.1080/20016689.2017.1372025. eCollection 2017. J Mark Access Health Policy. 2017. PMID: 29081921 Free PMC article.
Lack of tolerable treatment options for patients with schizophrenia.
Citrome L, Eramo A, Francois C, Duffy R, Legacy SN, Offord SJ, Krasa HB, Johnston SS, Guiraud-Diawara A, Kamat SA, Rohman P. Citrome L, et al. Neuropsychiatr Dis Treat. 2015 Dec 16;11:3095-104. doi: 10.2147/NDT.S91917. eCollection 2015. Neuropsychiatr Dis Treat. 2015. PMID: 26719694 Free PMC article.
Clobazam and clonazepam use in epilepsy: Results from a UK database incident user cohort study.
Brodie MJ, Chung S, Wade A, Quelen C, Guiraud-Diawara A, François C, Verpillat P, Shen V, Isojarvi J. Brodie MJ, et al. Epilepsy Res. 2016 Jul;123:68-74. doi: 10.1016/j.eplepsyres.2016.04.003. Epub 2016 Apr 11. Epilepsy Res. 2016. PMID: 27135706
Cost-effectiveness of vortioxetine versus venlafaxine (extended release) in the treatment of major depressive disorder in South Korea.
Choi SE, Brignone M, Cho SJ, Jeon HJ, Jung R, Campbell R, Francois C, Milea D. Choi SE, et al. Expert Rev Pharmacoecon Outcomes Res. 2016 Oct;16(5):629-638. doi: 10.1586/14737167.2016.1128830. Epub 2016 Jan 13. Expert Rev Pharmacoecon Outcomes Res. 2016. PMID: 26641142
A tolerability burden index in schizophrenia: incorporating patient perspective in clinical trial adverse event reporting.
François C, Guiraud-Diawara A, Lançon C, Llorca PM, Hartry A, Hammer-Helmich L, Zighed DA, Tanasescu A, Toumi M. François C, et al. J Mark Access Health Policy. 2017 Sep 13;5(1):1372026. doi: 10.1080/20016689.2017.1372026. eCollection 2017. J Mark Access Health Policy. 2017. PMID: 29081922 Free PMC article.
642 results
Jump to page